Nicholas W. Bath Jr.

Understanding The Potential Implications Of A Government Shutdown On Health Care Agencies And Personnel

Court Strikes Down FDA's Final Rule On Laboratory-Developed Tests

Evaluation Of Drug Pricing Policies Under A Potential Reconciliation Package

FDA Finalizes Rule To Phase Out Enforcement Discretion Of Laboratory-Developed Tests

The FDA And The Future Of AI Oversight

Strengthening The No Surprises Act's Independent Dispute Resolution Process: Stakeholder Perspectives

Biden Administration Seeks $500M To Implement And Enforce No Surprises Act And Mental Health Parity